Adia Nutrition Inc (PK) (ADIA) ニュース

These 8s and 9s are a sticky point but we'll get there.

Gotta Break Out Over these Pesky 9s!

$ADIA is Up and Green!

You dont know the difference between a patent and a trademark application do you?

Lots of eyes on $ADIA despite slowed momentum! https://investorshub.advfn.com/boards/tcloud.aspx

This is still a strong buy here according to barchart opinion! https://www.barchart.com/stocks/quotes/ADIA/opinion

$ADIA

Yesterday's patent news was an awesome update for ADIA. Expecting to see .10 break this week.

Adia Nutrition Moves to Secure Brand Identity with Trademark Filings
https://www.newsfilecorp.com/release/243145/Adia-Nutrition-Moves-to-Secure-Brand-Identity-with-Trademark-Filings
✅ Secures brand protection and trust.
✅ Introduces cutting-edge stem cell therapy.
✅ Sets a new industry standard.

yes were bout ready to go over .10 and not look back

Nice bids going into close, stacked at .08.
$ADIA

Fat bid sitting at .065.

Quarter is within reach! OTCQB is a Big Catalyst!

thx

I'm still calling for a quarter next month. I've been sticking by this for several months now. Just my opinion and as always do your own DD.

Loading as much as I can! UUUUGGGEEEEE

Great post/summary of what's at play here!

Nice! Trademark filings strengthen ADIA's brand identity.

U.S. Patent and Trademark Office (USPTO) for its new product, "Adia Vita, " and its bold slogan, "The Platinum Standard in Stem Cell Therapy," both now pending approval.

"With 'Adia Vita' and 'The Platinum Standard,' we're locking in our vision for innovation and trust.

lol

agreed

Another great update. "Filing for these trademarks is about more than just legal protection—it's about promising our customers the real deal, every time," Powalisz added. "With 'Adia Vita' and 'The Platinum Standard,' we're locking in our vision for innovation and trust."

More great news

Patent news out! $ADIA

In a bold move to solidify its position in the competitive field of regenerative medicine, ADIA Nutrition Inc. (OTC Pink: ADIA) has filed for trademarks on its newest product, "Adia Vita," and its powerful new slogan, "The Platinum Standard in Stem Cell Therapy." These trademark applications, currently pending approval by the U.S. Patent and Trademark Office (USPTO), aim to protect ADIA’s innovation and ensure that its stem cell therapies remain synonymous with excellence. As the stem cell market grows rapidly, ADIA Nutrition stands out with its commitment to authenticity and superior offerings. The company’s CEO, Larry Powalisz, emphasized that these trademarks are about more than just legal protection—they represent ADIA’s promise to deliver the real deal to customers and healthcare providers alike. With Adia Vita and "The Platinum Standard," ADIA is setting the stage for the future of stem cell therapy.

Adia Nutrition Moves to Secure Brand Identity with Trademark Filings
https://www.newsfilecorp.com/release/243145/Adia-Nutrition-Moves-to-Secure-Brand-Identity-with-Trademark-Filings

patent news https://www.otcmarkets.com/stock/ADIA/news/Adia-Nutrition-Moves-to-Secure-Brand-Identity-with-Trademark-Filings?id=469676

Once an OTC grifter, always an OTC grifter. Question is, will this past conviction affect their supposed plans to uplist?

Looking ahead, ADIA plans to replicate its successful clinic model in new markets, expand satellite locations, and complete its uplisting to the OTCQB Venture Market.

ADIAs Florida clinic has exceeded financial expectations in its first month of operation!

ADIA is gonna be a huge successful company! Put him on ignore. Lol. Let's leave him in the dust crying!

Did you really just pull up a 15 year old court case to attempt to prove your point?

"There being no just reason for delay, pursuant to Rule 54(b) of the Federal Rules of Civil
Procedure, the Clerk is ordered to enter this Final Judgment forthwith and without further notice.
DONE and ORDERED in Chambers, in Orlando, Florida this 18 day of August, 2010."

ADIA Moving Along Nicely with or without you! Gl

Is this proof enough? https://www.sec.gov/files/Judg09-cv-01638Powalisz.pdf

Uplisting to OTCQB! Takes a while. Once that happens, many will jump on board.

I have quite a few shares with this company so I want it to be successful. I just want it done clean. No pumping and no dumping. I put a particular poster on ignore because he's nothing more than a naysayer with probably zero investment. I dislike naysayers without proof. Current proof not historical proof.

Shareholders should know soon if this company is going anywhere. I'm staying positive.

Especially when there is an offering out at .005 that the CEO wont close out even though "he doesnt need it" and the CEO was formally convicted of fraud with the SEC.

Evidently, investors aren't convinced that this is real. Something is preventing investors from coming aboard. I do know all these posts about news (many reduntant) aren't helping. It gives the appearance of pumping the stock. JMO

Feature in Nasdaq today!
The global stem cell therapy market is entering an era of unprecedented growth and innovation. Valued at $5.13 billion in 2024, the U.S. stem cell market alone is projected to reach $15.79 billion by 2034, growing at a compound annual growth rate (CAGR) of 11.9%. Globally, the market is expected to hit $28.89 billion by 2030, fueled by advancements in regenerative medicine, increased government funding for research, and the development of groundbreaking therapies for conditions like cancer, autoimmune diseases, and genetic disorders.

Nasdaq: The Future of Stem Cell Investing: Spotlight on Smaller Innovators #StemCellTherapy
https://www.nasdaq.com/press-release/future-stem-cell-investing-spotlight-smaller-innovators-2025-03-04

I've loaded more @.08 today! Wooohooo, adding to my stash!

I don't expect to see much revenue yet. But wait until they get that clinic approval from the state of Florida, which indirectly allows the private insurers to start paying for treatments, maybe several more weeks down the road.

Plus, when we see a sales team onboard who has experience selling to Med Spa types of businesses (nearly 9,000 of those types of businesses in the U.S. in 2022), then sales can grow very rapidly. We're just starting to launch at the moment.

Q1 should have little revenue; Q2 could go ballistic! Trying to load more before the real fireworks begin.

Sure. The daily PR though, especially with paid promo articles like this, makes me question what the motive is. Ill wait to see results in the financials, but you wont see that until the next quarterly after the annual. Thats usually why they ramp up these promotions where no one can see concrete results in the financials.

OTCQB

If we get lucky, the Nasdaq correction might end in the next couple of hours! Then, March Madness can begin!

Nothing wrong with promos if they are backed up by a legitimate business. It's just another form of advertising. New investors can learn a lot via the X site, @ADIA_Nutrition. You can even watch a video walk-through of the business.

Here is what was written about $ADIA in a new Nasdaq article out that is spotlighting smaller stem cell companies:
ADIA Nutrition Inc. (OTC: ADIA) is on a mission to transform healthcare through innovation in regenerative medicine and premium organic supplements. Operating under two key divisions—its supplement arm and Adia Med, its medical division—the company is making waves in the fast growing global stem cell market. With cutting-edge therapies like Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT), ADIA Nutrition is empowering patients to address conditions ranging from autoimmune disorders to orthopedic injuries.

2025 has been a landmark year for ADIA Nutrition, with groundbreaking achievements that emphasize innovation and accessibility. In March, the company celebrated the FDA registration of Adia Vita, its premier stem cell product. This allows Adia Vita to be distributed nationwide, significantly expanding access to regenerative medicine. "This acceptance reflects Adia Labs' commitment to broadening access," said Larry Powalisz, CEO of ADIA Nutrition. The registration enhances patient access and opens new revenue opportunities.

In February, ADIA announced a strategic expansion plan by partnering with elite Medical Spas to create satellite locations across the U.S. This low-cost model will offer treatments like UCB-SC therapies and stem cell injectables to health-conscious regions, tapping into an existing customer base and creating revenue streams via service fees, royalties, and equity interests. "This expansion is a testament to our commitment to making therapies more accessible," Powalisz said.

The launch of Adia Labs LLC in February solidified ADIA’s leadership in regenerative medicine. Adia Labs introduced AdiaVita, a high-potency stem cell product containing 100 million cells and 3 trillion exosomes per dose, designed for clinical research and therapeutic use. A future product, AdiaLink, will contain 3.5 trillion exosomes, pushing the boundaries of medical science. "We are advancing medical science while maintaining the highest standards of safety and quality," Powalisz stated.

A key to ADIA’s success is its partnership with a premier FDA-approved laboratory, ensuring the highest quality stem cell and exosome products. Each dose is third-party verified for purity, potency, and safety, making it a trusted choice for medical professionals. "After months of due diligence, we offer the best quality therapies per treatment," Powalisz noted. This partnership guarantees a steady supply of top-tier products.

ADIA is also working to secure private insurance coverage for treatments like aHSCT and injectable stem cells, reducing the financial burden on patients and expanding access. "Registering with the AHCA is a monumental step in providing open access to our therapies," Powalisz said. The company’s integration into the mainstream healthcare ecosystem is gaining traction, with several patients already preapproved by private insurers.

The Winter Park, Florida clinic has exceeded financial expectations in its first month of operation, offering FDA-compliant treatments for conditions like Multiple Sclerosis, hip issues, and joint pain. "Many patients have traveled abroad for treatments we now offer locally," said Dr. Monica Sher, Chief Stem Cell Medical Officer at Adia Med.

Looking ahead, ADIA plans to replicate its successful clinic model in new markets, expand satellite locations, and complete its uplisting to the OTCQB Venture Market. With aspirations for a Nasdaq listing, the company could be poised for significant growth. "From January's financial win to February's breakthroughs, we’re redefining healthcare possibilities," Powalisz added. "We’re committed to innovation and sustainable growth."

For investors, ADIA offers a unique opportunity to be part of a company revolutionizing healthcare. With its innovative treatments, strategic partnerships, and commitment to quality, ADIA Nutrition is well-positioned to lead the regenerative medicine industry.

https://www.nasdaq.com/press-release/future-stem-cell-investing-spotlight-smaller-innovators-2025-03-04

Paid promo article by this company that these guys always use across their tickers (APSI, ADIA, GMZP, INKW, TLIF)

RazorPitch
Mark McKelvie
+1 585-301-7700
mark@razorpitch.com

https://www.nasdaq.com/press-release/future-stem-cell-investing-spotlight-smaller-innovators-2025-03-04

So many things happening with this one, when will this consolidation end so we can move up on this news? 

UUUGGGEEEE NEWS TODAY! Adia Labs' notification to the FDA that it will be storing and distributing its premier stem cell product, Adia Vita, to doctors and clinics nationwide.
"Registering Adia Vita with the FDA marks a game-changing moment for us, " said Larry Powalisz, CEO of ADIA Nutrition. "We're deeply grateful to the FDA for their timely and cooperative efforts in making this registration possible so quickly.

Looking better all the time.

Churning green all day. CEO posted a follow up to today's PR >> https://x.com/ADIA_Nutrition/status/1896651378300207340

$ADIA

OTCQB Uplisting! Last piece of the puzzle!